Amedisys Inc
NASDAQ:AMED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
89.45
98.45
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AMED stock under the Base Case scenario is 115.66 USD. Compared to the current market price of 90.64 USD, Amedisys Inc is Undervalued by 22%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Amedisys Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Amedisys Inc
Balance Sheet Decomposition
Amedisys Inc
Current Assets | 579.9m |
Cash & Short-Term Investments | 245.5m |
Receivables | 301.1m |
Other Current Assets | 33.4m |
Non-Current Assets | 1.6B |
PP&E | 127.1m |
Intangibles | 1.3B |
Other Non-Current Assets | 87.7m |
Current Liabilities | 486m |
Accounts Payable | 32.1m |
Accrued Liabilities | 310.4m |
Other Current Liabilities | 143.5m |
Non-Current Liabilities | 505.3m |
Long-Term Debt | 344.4m |
Other Non-Current Liabilities | 160.9m |
Earnings Waterfall
Amedisys Inc
Revenue
|
2.3B
USD
|
Cost of Revenue
|
-1.3B
USD
|
Gross Profit
|
1B
USD
|
Operating Expenses
|
-804.7m
USD
|
Operating Income
|
208.9m
USD
|
Other Expenses
|
-126m
USD
|
Net Income
|
82.9m
USD
|
Free Cash Flow Analysis
Amedisys Inc
USD | |
Free Cash Flow | USD |
AMED Profitability Score
Profitability Due Diligence
Amedisys Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Amedisys Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
AMED Solvency Score
Solvency Due Diligence
Amedisys Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Amedisys Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMED Price Targets Summary
Amedisys Inc
According to Wall Street analysts, the average 1-year price target for AMED is 99.32 USD with a low forecast of 73.73 USD and a high forecast of 106.05 USD.
Dividends
Current shareholder yield for AMED is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
AMED Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 21,000 full-time employees. The firm operates through four segments: Home Health, Hospice, Personal Care and high acuity care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. Its high acuity care segment delivers the essential elements of inpatient hospital and skilled nursing facility (SNF) care to patients in their homes. The firm owns and operates approximately 530 care centers in 38 states.
Contact
IPO
Employees
Officers
The intrinsic value of one AMED stock under the Base Case scenario is 115.66 USD.
Compared to the current market price of 90.64 USD, Amedisys Inc is Undervalued by 22%.